SEC Form 4 · accession 0000911916-18-000029
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bryan C Hanson
Officer — President and CEO · Director
Period of report
Feb 15, 2018
Accepted (ET)
Feb 20, 2018 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 15, 2018 | P | 12,602 | $119.6011 | A | 12,602 | D | |
| Common StockF2 | Feb 15, 2018 | P | 11,915 | $119.7766 | A | 24,517 | D | |
| Common Stock | Feb 16, 2018 | P | 545 | $119.3773 | A | 25,062 | D | |
| Common Stock | Feb 20, 2018 | P | 15 | $119.859 | A | 25,077 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the purchase of 12,602 shares in multiple transactions, ranging in price from $118.72 to $119.71 per share, resulting in a weighted average purchase price of $119.6011. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
- F2Represents the purchase of 11,915 shares in multiple transactions, ranging in price from $119.715 to $119.895 per share, resulting in a weighted average purchase price of $119.7766. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.